Inferring progression models for CGH data

Bioinformatics

Volumn 25, Issue 17, 2009, Pages 2208-2215

  Liu, Jun ^a   Bandyopadhyay, Nirmalya ^a   Ranka, Sanjay ^a   Baudis, M ^b   Kahveci, Tamer ^a  

^a University of Florida   (United States)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TUMOR MARKER;

ARTICLE; CANCER GROWTH; COMPARATIVE GENOMIC HYBRIDIZATION; DATA BASE; DNA STRUCTURE; GENE DELETION; GENE OVEREXPRESSION; MULTIPLE CANCER; NEOPLASM; ONCOGENE; PHYLOGENETIC TREE; PRIORITY JOURNAL; STATISTICAL MODEL; TUMOR SUPPRESSOR GENE;

COMPARATIVE GENOMIC HYBRIDIZATION; GENE DOSAGE; HUMANS; MODELS, GENETIC; NEOPLASMS; PHYLOGENY; TUMOR MARKERS, BIOLOGICAL;

EID: 69949122581     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btp365     Document Type: Article

References (25)

1. Baudis,M. (2007) Genomic imbalances in 5918 malignant epithelial tumors: an explorative meta-analysis of chromosomal CGH data. BMC Cancer, 7, 226.
2. Baudis,M. and Cleary,M.L. (2001) Progenetix.net: An online repository for molecular cytogenetic aberration data. Bioinformatics, 17 1228-1229.
3. Bilke,S. et al. (2005) Inferring a tumor progression model for neuroblastoma from genomic data. J. Clin. Oncol., 23, 7322-7331.
4. Desper,R. et al. (2000) Distance-based reconstruction of tree models for oncogenesis. J. Comput. Biol., 7, 789-803.
5. Desper,R. et al. (1999) Inferring tree models for oncogenesis from comparative genome hybridization data. J. Comput. Biol., 6, 37-52.
6. Forozan,F. et al. (1997) Genome screening by comparative genomic hybridization. Trends Genet., 13, 405-409.
7. Felsenstein,J. (1989)PHYLIP - Phylogeny Inference Package (Version 3.2). Cladistics, 5, 164-166.
8. Gray,J.W. et al. (1994) Molecular cytogenetics of human breast cancer. Cold Spring Harb. Symp. Quant. Biol., 59, 645-652.
9. Hoglund,M. et al. (2005) Statistical behavior of complex cancer karyotypes. Genes Chromosomes Cancer, 42, 327-341.
10. Hsu,L. et al. (2005) Denoising array-based comparative genomic hybridization data using wavelets. Biostatistics, 6, 211-226.
11. Jain,A.N. et al. (2001) Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival. Proc. Natl Acad. Sci. USA, 98, 7952-7957.
12. Joos,S. et al. (2002) Classical hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. Blood, 99, 1381-1387.
13. Kallioniemi,A. et al. (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science, 258 818-821.
14. Katoh,T. et al. (1996) Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis, 17, 1855-1859.
15. Kurzrock,R. et al. (1995) Abnormalities in the PRAD1 (CYCLIN D1/ BCL-1) oncogene are frequent in cervical and vulvar squamous cell carcinoma cell lines. Cancer, 75, 584-590.
16. Lee,J.W. et al. (2005) PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. Oncogene, 24, 1477-1480.
17. Liu,J. et al. (2007) Markers improve clustering of CGH data. Bioinformatics, 23, 450-457.
18. Mattfeldt,T. et al. (2001) Cluster analysis of comparative genomic hybridization cgh data using self-organizing maps: Application to prostate carcinomas. Anal. Cell. Pathol., 23, 29-37.
19. Mitelman,F. (ed.) (1995) International System for Cytogenetic Nomenclature. Karger, Basel.
20. Pennington,G. et al. (2006) Cancer phylogenetics from single-cell assays. Technical Report CMU-CS-06-103, School of Computer Science, Carnegie Mellon University, Pittsburgh.
21. Pinkel,D. and Albertson,D.G. (2005) Array comparative genomic hybridization and its applications in cancer. Nat. Genet., 37 (Suppl.), S11-S17.
22. Reya,T. et al. (2001) Stem cells, cancer, and cancer stem cells. Nature, 414, 105-111.
23. Tan,P.-N. et al. (2005) Introduction to Data Mining, 1st edn. Addison Wesley, Boston, MA.
24. Vandesompele,J. et al. (2005) Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma. J. Clin. Oncol., 23, 2280-2299.
25. Vogelstein,B. et al. (1988) Genetic alterations during colorectal-tumor development. N. Engl. J. Med., 319, 525-532.